These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1671820)

  • 1. Correlation of mdr status with clinical outcome in patients with acute myeloblastic leukemia.
    Holmes JA; West RR; Whittaker JA; Jacobs A
    Br J Haematol; 1991 Jan; 77(1):130-1. PubMed ID: 1671820
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
    Holmes JA; West RR
    Br J Cancer; 1994 Feb; 69(2):382-4. PubMed ID: 7905280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16 or FAB M4Eo subtype.
    Zöchbauer S; Haas OA; Schwarzinger I; Lechner K; Pirker R
    Lancet; 1994 Sep; 344(8926):894. PubMed ID: 7916430
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?
    Baccarani M; Michieli M; Damiani D; Michelutti A
    Blood; 1992 Aug; 80(4):1094-5. PubMed ID: 1353994
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
    Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
    Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis.
    Marie JP; Legrand O; Russo D; Zhou D; Suberville AM; Zittoun R
    Leuk Lymphoma; 1992 Nov; 8(4-5):261-5. PubMed ID: 1363283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of P-gp expression and related function in childhood acute leukemia.
    Karakaş Z; Ağaoğlu L; Erdem S; Demirel GY; Arasa M; Süzergöz F; Deniz G; Anak S; Gedikoğlu G
    Adv Exp Med Biol; 1999; 457():21-8. PubMed ID: 10500776
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative analysis of MDR-1 gene expression in acute myeloid leukemia by reverse transcription polymerase chain reaction.
    Cao QX; Schulz A; Scheid C; Wickramanayake PD
    Am J Hematol; 1996 Aug; 52(4):329. PubMed ID: 8701958
    [No Abstract]   [Full Text] [Related]  

  • 10. Negative impact of FLT3-ITD mutation on expression of MDR-1 mRNA in adult acute myeloid leukemia.
    Nasiłowska-Adamska B; Solarska I
    Leuk Lymphoma; 2012 Dec; 53(12):2523-6. PubMed ID: 22591177
    [No Abstract]   [Full Text] [Related]  

  • 11. WAVE1 regulates P-glycoprotein expression via Ezrin in leukemia cells.
    Yang MH; Zhao MY; Wang Z; Kang R; He YL; Yin XC; Liu LY; Yang LC; Zhan CX; Wu XS; Tang DL; Cao LZ
    Leuk Lymphoma; 2011 Feb; 52(2):298-309. PubMed ID: 21281239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
    Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
    Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications.
    Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Lane SA; Nancarrow JK; Whitmore SA
    Lancet; 1994 Jun; 343(8912):1531-4. PubMed ID: 7911871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB5 gene amplification in human leukemia cells.
    Frank NY; Frank MH
    Leuk Res; 2009 Oct; 33(10):1303-5. PubMed ID: 19477512
    [No Abstract]   [Full Text] [Related]  

  • 15. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
    Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
    Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update.
    Gsur A; Zöchbauer S; Götzl M; Kyrle PA; Lechner K; Pirker R
    Leuk Lymphoma; 1993 Dec; 12(1-2):91-4. PubMed ID: 7909245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.
    Clifford SC; Thomas DJ; Neal DE; Lunec J
    Br J Cancer; 1994 Apr; 69(4):680-6. PubMed ID: 7908215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.
    Kuwazuru Y; Yoshimura A; Hanada S; Utsunomiya A; Makino T; Ishibashi K; Kodama M; Iwahashi M; Arima T; Akiyama S
    Cancer; 1990 Sep; 66(5):868-73. PubMed ID: 1974821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance (mdr) genes in human cancer.
    Nooter K; Herweijer H
    Br J Cancer; 1991 May; 63(5):663-9. PubMed ID: 1674875
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias.
    Larkin A; Moran E; Alexander D; Clynes M
    Adv Exp Med Biol; 1999; 457():65-70. PubMed ID: 10500781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.